Non-selective beta blocker use is associated with improved short-term survival in patients with cirrhosis referred for liver transplantation

BACKGROUND: Recent evidence cautions against the use of non-selective beta-blockers (NSBB) in patients with refractory ascites or spontaneous bacterial peritonitis while other data suggests a survival benefit in patients with advanced liver disease. The aim of this study was to describe the use and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngwa, Taiwo, Orman, Eric, Gomez, Eduardo Vilar, Vuppalanchi, Raj, Kubal, Chandrashekhar, Chalasani, Naga, Ghabril, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945622/
https://www.ncbi.nlm.nih.gov/pubmed/31906860
http://dx.doi.org/10.1186/s12876-019-1155-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945622/
https://www.ncbi.nlm.nih.gov/pubmed/31906860
http://dx.doi.org/10.1186/s12876-019-1155-1

Ejemplares similares